GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anti-Microbial Savior BioteQ Co Ltd (ROCO:6864) » Definitions » Research & Development

Anti-Microbialvior BioteQ Co (ROCO:6864) Research & Development : NT$53.54 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Anti-Microbialvior BioteQ Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Anti-Microbialvior BioteQ Co's Research & Development for the six months ended in Dec. 2024 was NT$29.44 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was NT$53.54 Mil.


Anti-Microbialvior BioteQ Co Research & Development Historical Data

The historical data trend for Anti-Microbialvior BioteQ Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anti-Microbialvior BioteQ Co Research & Development Chart

Anti-Microbialvior BioteQ Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 15.77 21.22 31.63 45.12 53.54

Anti-Microbialvior BioteQ Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.50 21.72 23.40 24.10 29.44

Anti-Microbialvior BioteQ Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$53.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anti-Microbialvior BioteQ Co  (ROCO:6864) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Anti-Microbialvior BioteQ Co Research & Development Related Terms

Thank you for viewing the detailed overview of Anti-Microbialvior BioteQ Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Anti-Microbialvior BioteQ Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Siwei 3rd Road, 7th Floor-2, Lingya District, Kaohsiung, TWN, 741
Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.

Anti-Microbialvior BioteQ Co Headlines

No Headlines